scholarly journals An Analysis of Circulating Betatrophin Levels in Relation with Type1 and Type2 Diabetes Mellitu Running Title: Betatrophin and Diabetes

2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Altunoglu Esma ◽  
Erdenen Fusun ◽  
Aydın Seda ◽  
Koro Atakan ◽  
Uzun Hafize
Keyword(s):  
Type2 Diabetes

Ghrelin and Obesity-An Update

2017 ◽  
Vol 9 (1) ◽  
Author(s):  
Gandhi M. ◽  
Swaminathan S.
Keyword(s):  
Diabetes Mellitus ◽  
Cardiac Output ◽  
Energy Balance ◽  
Vascular Resistance ◽  
The Body ◽  
Ghrelin Receptor ◽  
Type2 Diabetes ◽  
Type2 Diabetes Mellitus ◽  
Natural Hormones

Ghrelin as human natural hormones is involved in fundamental regulatory process of eating and energy balance. It is a stomach derived hormone that acts as at the ghrelin receptor in multiple tissues throughout to the body. Its properties includes increasing appetite, decreasing systemic inflammation, decreasing vascular resistance ,increasing cardiac output, increasing glucose and IGF-1 levels, Hence it may play a significant role in Diabetes mellitus. Many studies have linked ghrelin to obesity and this paper is an attempt to bring out recent findings on the role of ghrelin in Diabetes Mellitus, particularly type2 Diabetes mellitus.

Serum level of Arginine and Symmetric dimethyl arginine in patients with prediabetes and type2 diabetes mellitus

2019 ◽  
Vol 22 (12) ◽  
pp. 218-226
Author(s):  
Basheer Sultan Dayir ◽  
Mohammed I. Hamzah ◽  
Mahmood S.H. Khudair
Keyword(s):  
Diabetes Mellitus ◽  
Serum Level ◽  
Type2 Diabetes ◽  
Type2 Diabetes Mellitus ◽  
Dimethyl Arginine

SEX HORMONE BINDING GLOBULIN GENE POLYMORPHISM AND RISK OF TYPE2 DIABETES MELLITUS IN EGYPTIAN MEN

2014 ◽  
Vol 20 (2) ◽  
pp. 1-7
Author(s):  
Shereen El Tarhouny ◽  
Soha Zakaria ◽  
Khaled d Hadhoud ◽  
Manal Hanafi ◽  
Azza Kamel ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Gene Polymorphism ◽  
Sex Hormone ◽  
Sex Hormone Binding Globulin ◽  
Hormone Binding ◽  
Type2 Diabetes ◽  
Type2 Diabetes Mellitus ◽  
Globulin Gene

scholarly journals Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Ming Yang ◽  
Tamana Darwish ◽  
Pierre Larraufie ◽  
Debra Rimmington ◽  
Irene Cimino ◽  
...  
Keyword(s):  
Mitochondrial Dysfunction ◽  
Glucose Uptake ◽  
Intestinal Cell ◽  
Cell Physiology ◽  
Sequencing Analysis ◽  
Extracellular Acidification ◽  
Type2 Diabetes ◽  
Site Of Action ◽  
Glycolytic Rate ◽  
Hexose Metabolism

AbstractEven though metformin is widely used to treat type2 diabetes, reducing glycaemia and body weight, the mechanisms of action are still elusive. Recent studies have identified the gastrointestinal tract as an important site of action. Here we used intestinal organoids to explore the effects of metformin on intestinal cell physiology. Bulk RNA-sequencing analysis identified changes in hexose metabolism pathways, particularly glycolytic genes. Metformin increased expression of Slc2a1 (GLUT1), decreased expression of Slc2a2 (GLUT2) and Slc5a1 (SGLT1) whilst increasing GLUT-dependent glucose uptake and glycolytic rate as observed by live cell imaging of genetically encoded metabolite sensors and measurement of oxygen consumption and extracellular acidification rates. Metformin caused mitochondrial dysfunction and metformin’s effects on 2D-cultures were phenocopied by treatment with rotenone and antimycin-A, including upregulation of GDF15 expression, previously linked to metformin dependent weight loss. Gene expression changes elicited by metformin were replicated in 3D apical-out organoids and distal small intestines of metformin treated mice. We conclude that metformin affects glucose uptake, glycolysis and GDF-15 secretion, likely downstream of the observed mitochondrial dysfunction. This may explain the effects of metformin on intestinal glucose utilisation and food balance.

scholarly journals Korelasi Jumlah Netrofil, Limfosit, dan Monosit dengan Kadar Albumin Urin pada Pasien DM Tipe 2 dengan Mikroalbuminuria

Biomedika ◽  
2009 ◽  
Vol 1 (1) ◽  
Author(s):  
Edy Purwanto
Keyword(s):  
Type 2 Diabetes ◽  
Albumin Level ◽  
Cost Of Care ◽  
Monocyte Count ◽  
Cross Sectional ◽  
Urine Albumin ◽  
Type2 Diabetes ◽  
Coefficient Corrélation ◽  
Analyzer Cell

The most common complication of diabetes is diabetic nephropathy which is a progressive disease and in the terminal stages, needs a very large cost of care. Nephropathy diabetic can be prevented if it is detected earlier. Microalbuminuria is a test to detect nepropathy diabetic early nowadays, but it is still considered expensive by the majority of the community and has not been widely done in laboratories. What ever it needs other alternatives, such as neutrophils, lymphocyte, and monocyte counts. The purpose of this study is to analyse the correlations between neutrophils, lymphocyte, monocyte counts and urine albumin levels in type2 diabetes with microalbuminuria. The research design is analytic observational with cross sectional approach. Twenty two patients met the inclusion criteria. Their urine albumin levels tested by Nycocard® U-ALBUMIN reagent. Neutrophils, lymphocyte, monocyte count was examined by hematology analyzer CELL-Dyn 3700. The correlations between neutrophils, lymphocyte, monocyte counts and urine albumin levels analyzed using coefficient correlation Spearman's. No correlation between neutrophil countsand urine albumin levels (r= -0,250;p=0,263). No correlation between monocyte counts and urine albumin levels (r= -0,191;p=0,395). No correlation between lymphocyte counts and urine albumin levels (r=0,130;p=0,565) in type 2 diabetes with microalbuminuria. No correlation between neutrophils, lymphocyte, monocyte counts and urine albumin level in type 2 diabetes patients with microalbuminuriaKeywords: type 2 diabetes, neutrophils, lymphocytes, monocytes, microalbuminuria.

scholarly journals A study on association of polymorphisms in calpain10 and TCF7l2 genes with type 2 diabetes mellitus

Genetika ◽  
2015 ◽  
Vol 47 (1) ◽  
pp. 161-170 ◽  
Author(s):  
Maryam Rezazadeh ◽  
Nasim Sohrabifar ◽  
Hossein Jafari ◽  
Ardabili Mohaddes ◽  
Jalal Gharesouran
Keyword(s):  
Type 2 Diabetes ◽  
Allelic Association ◽  
Diabetic Patients ◽  
Control Groups ◽  
Type2 Diabetes ◽  
North Of Iran ◽  
Calpain 10 ◽  
The Difference ◽  
And Control

Polymorphisms of the Calpain10 and TCF7L2 genes were identified as possible type 2 diabetes susceptibility genetic markers. We conducted a case-control study to evaluate the relation between SNP43 of calpain-10 and rs12255372 and rs7903146 in the TCF7L2 with type2 diabetes in western-north of Iran. The role of these variants in Iranian population was less clear. A total of 202 patients and healthy controls were enrolled to analysis the frequency distribution of Calpain10 and TCF7L2 polymorphisms (SNP43, rs12255372 and rs7903146) using polymerase chain reaction-restriction fragment length polymorphism (PCR - RFLP) method. The frequency of allele A in controls was significantly greater than that of diabetic patients (P=0.031), whereas the difference between distribution of SNP43 genotypes (A/A, A/G, G/G) were non- significant in case and control groups. Non significant association was also observed between G/G, A/G or A/A genotypes and type 2 Diabetes. The frequency of the ?T? allele of rs12255372 (G/T) was significantly associated with type 2 diabetes (OR= 0.55, 95% confidence interval [CI], 1.11-1.51; P<0.001). No allelic association was found for rs7903146(C/T) polymorphism. The distribution of alleles in case and control groups are significantly different indicating the G allele is associated with type 2 diabetes. The rs12255372 (G/T) may be associated with type 2 diabetes.

Sign in / Sign up

Export Citation Format

Share Document